Premarin Lawsuits – The Types Of Settlement Offers
Premarin lawsuits, which are brought by plaintiffs who were treated with Premarin (a prescription medicine for enlarged prostates), are at the center of the current lawsuit industry. As of now, there are over 100 plaintiffs suing pharmaceutical companies, including Pfizer. And in the last few months, there have been a number of settlements involving Premarin lawsuits.
Last month, Pfizer announced that it had settled almost 5,500 Prempro and premarin lawsuits over the past three years. In a recent October 15th filing with the Securities and Exchange Commission, Pfizer disclosed that it had settled more than $3 billion in claims related to Premarin, including claims against Wyeth, Janssen, and Endo International. According to an October 15th article published by the Wall Street Journal, the settlements included a combination of consumer claims and litigation settlements. However, the article did not indicate which claims were settled and which were settled by litigation.
Of course, as these lawsuits proceed through the litigation process, plaintiffs often adjust their compensation claims to include financial damages such as loss of wages, medical costs, and the associated medical expenses. For plaintiffs who lost wages and medical expenses due to Premarin related injuries, the settlements included a percentage of these awards that can be used for damages and medical bills. The percentage ranges from roughly ten percent for plaintiffs who lost their livelihoods due to Premarin related injuries to nearly one hundred percent for plaintiffs who had their ability to work with limited or permanently damaged by the use of Premarin.
As a matter of law, settlement amounts for Premarin related injuries are non-refundable. Therefore, if you choose to seek a settlement, the amount you receive is not based on your initial assessment of the injury, but based on a percentage of your claim. While this type of award may be an appropriate alternative to a lawsuit, you should make sure that your attorney is aware of this option before proceeding.
The second most common type of settlement is a payment schedule, in which the plaintiff’s case is settled in installments over a period of time. Some Premarin lawsuits involve plaintiffs who are seeking just monetary awards. Others are seeking both monetary and non-monetary awards. Some Premarin cases are settled for pennies on the dollar while others go for thousands of dollars.
Some plaintiffs who have settled in these cases, including those from both Premarin and Wyeth, chose a litigation settlement because they do not have the resources to pursue a claim through the courts. However, if a plaintiff decides to pursue a lawsuit, then the amount of cash received will vary depending on the severity of the injury and the amount of settlement the plaintiff can obtain. For example, a Premarin lawsuit may result in a claim of $20 million or more while a non-Premarin lawsuit may result in a claim of a few thousand dollars or a few hundred.
In some cases, the settlement amount of a lawsuit is more than the settlement amount of a settlement amount in a settlement offer. For instance, a patient who has been treated for a severe traumatic brain injury may be awarded several times the original settlement amount after the court proceedings. The amount of any future settlements will also depend on the plaintiff’s medical expenses and the amount of damage done. In many cases, if a patient loses the ability to work or suffers long term injuries, it is possible to collect compensation from the pharmaceutical company that manufactured Premarin.
The next few articles will discuss the details of Premarin litigation settlements. In addition, we will examine the process for obtaining monetary awards under the terms of a settlement offer and consider the merits of obtaining a settlement offer in the first place. The information contained in this article is not legal advice and is for information only. If you need legal assistance, you should consult with a qualified lawyer.